Abstract (R)-3-(p-t-Butylphenylthio)cyclohexan-1-one was reduced with LiAlH(OBut)3 to afford (1S,3R)-3-(p-t-butylphenylthio)cyclohexan-1-o1, while the same reduction with LiBH(s-Bu)3 afforded the (1R,3R) counterpart almost exclusively. Elaboration of each product furnished both enantiomers of optically pure cyclohexenol derivatives.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: